Cardiff by the Sea, CA, United States of America

Thomas C Hermann

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.3

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2007-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Thomas C Hermann: Innovator in Antiviral and Antibacterial Compounds

Introduction

Thomas C Hermann, based in Cardiff by the Sea, California, is a prominent inventor holding two patents in the fields of antiviral and antibacterial compounds. His work reflects a dedication to advancing pharmaceutical technology and improving health outcomes.

Latest Patents

Hermann's recent patents include groundbreaking developments in antiviral and antibacterial treatments. One of his notable inventions is the creation of antiviral compounds aimed at treating HCV infection. This patent discusses compounds and methods of synthesis of specific formulas that facilitate the progress of antiviral drugs. Additionally, he has developed antibacterial compounds that are 3,5-diaminopiperidine-substituted aromatic and heteroaromatic. This invention focuses on pharmaceutical compositions to treat bacterial infections in mammals, particularly humans, demonstrating innovation in combating serious health issues.

Career Highlights

Throughout his career, Thomas C Hermann has contributed significantly to the pharmaceutical industry. He has held positions at Anadys Pharmaceuticals, Inc., where he was involved in cutting-edge drug development. Additionally, he worked in a research capacity at the University of California, furthering his impact on innovation in medicine.

Collaborations

Hermann's journey has been enriched through collaborations with esteemed colleagues such as Yuefen Zhou and Dionisios Vourloumis. These partnerships have played a crucial role in bolstering his research initiatives and in the successful development of his patented inventions.

Conclusion

In summary, Thomas C Hermann stands out as a forward-thinking inventor in antiviral and antibacterial treatments. His commitment to addressing critical health challenges through innovation is evidenced by his patents and collaborative efforts within the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…